126 related articles for article (PubMed ID: 30028622)
1. Simultaneous Delivery of Electrostatically Complexed Multiple Gene-Targeting siRNAs and an Anticancer Drug for Synergistically Enhanced Treatment of Prostate Cancer.
Choi E; Yoo W; Park JH; Kim S
Mol Pharm; 2018 Sep; 15(9):3777-3785. PubMed ID: 30028622
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of chemosensitizing siRNA and an anticancer agent via multiple monocomplexation-induced hydrophobic association.
Lee E; Oh C; Kim IS; Kwon IC; Kim S
J Control Release; 2015 Jul; 210():105-14. PubMed ID: 25979325
[TBL] [Abstract][Full Text] [Related]
3. Ultrasound-Guided Delivery of siRNA and a Chemotherapeutic Drug by Using Microbubble Complexes: In Vitro and In Vivo Evaluations in a Prostate Cancer Model.
Bae YJ; Yoon YI; Yoon TJ; Lee HJ
Korean J Radiol; 2016; 17(4):497-508. PubMed ID: 27390541
[TBL] [Abstract][Full Text] [Related]
4. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells.
Aliabadi HM; Mahdipoor P; Uludağ H
Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity.
Shen J; Liu J; Long Y; Miao Y; Su M; Zhang Q; Han H; Hao X
Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):223-30. PubMed ID: 19280061
[TBL] [Abstract][Full Text] [Related]
6. Novel fusion peptide-mediated siRNA delivery using self-assembled nanocomplex.
Ryu YC; Kim KA; Kim BC; Wang HD; Hwang BH
J Nanobiotechnology; 2021 Feb; 19(1):44. PubMed ID: 33579303
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA targeting HMGN5 induces apoptosis via modulation of a mitochondrial pathway and Bcl-2 family proteins in prostate cancer cells.
Zhang XY; Guo ZQ; Ji SQ; Zhang M; Jiang N; Li XS; Zhou LQ
Asian J Androl; 2012 May; 14(3):487-92. PubMed ID: 22504871
[TBL] [Abstract][Full Text] [Related]
8. Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small-molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids.
Oner E; Kotmakci M; Baird AM; Gray SG; Debelec Butuner B; Bozkurt E; Kantarci AG; Finn SP
J Nanobiotechnology; 2021 Mar; 19(1):71. PubMed ID: 33685469
[TBL] [Abstract][Full Text] [Related]
9. Downmodulation of Bcl-2 sensitizes metastatic LNCaP-LN3 cells to undergo apoptosis via the intrinsic pathway.
Song R; Harris LD; Pettaway CA
Prostate; 2010 May; 70(6):571-83. PubMed ID: 19938012
[TBL] [Abstract][Full Text] [Related]
10. Breathing New Life into TRAIL for Breast Cancer Therapy: Co-Delivery of pTRAIL and Complementary siRNAs Using Lipopolymers.
Thapa B; Kc R; Bahniuk M; Schmitke J; Hitt M; Lavasanifar A; Kutsch O; Seol DW; Uludag H
Hum Gene Ther; 2019 Dec; 30(12):1531-1546. PubMed ID: 31547718
[TBL] [Abstract][Full Text] [Related]
11. Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells.
Gunawardena K; Campbell LD; Meikle AW
Cancer Detect Prev; 2005; 29(4):389-95. PubMed ID: 16139439
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of skin squamous cell carcinoma proliferation and promote apoptosis by dual silencing of NET-1 and survivin.
Ji ZJ; Wang JL; Chen L
Oncol Rep; 2015 Aug; 34(2):811-22. PubMed ID: 26080853
[TBL] [Abstract][Full Text] [Related]
13. The chance of small interfering RNAs as eligible candidates for a personalized treatment of prostate cancer.
Pietschke K; Walker T; Krajewski S; Kurz J; Aufderklamm S; Schwentner C; Schlensak C; Stenzl A; Wendel HP; Nolte A
Curr Pharm Biotechnol; 2014; 14(13):1145-54. PubMed ID: 24853012
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia.
Jafarlou M; Shanehbandi D; Dehghan P; Mansoori B; Othman F; Baradaran B
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1792-1798. PubMed ID: 29113504
[TBL] [Abstract][Full Text] [Related]
15. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
[TBL] [Abstract][Full Text] [Related]
16. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro.
Rocchi P; Jugpal P; So A; Sinneman S; Ettinger S; Fazli L; Nelson C; Gleave M
BJU Int; 2006 Nov; 98(5):1082-9. PubMed ID: 16879439
[TBL] [Abstract][Full Text] [Related]
17. Improved delivery of Mcl-1 and survivin siRNA combination in breast cancer cells with additive siRNA complexes.
Santadkha T; Skolpap W; K C R; Ansari A; Kucharski C; Atz Dick T; Uludağ H
Invest New Drugs; 2022 Oct; 40(5):962-976. PubMed ID: 35834040
[TBL] [Abstract][Full Text] [Related]
18. Chitosan (CMD)-mediated co-delivery of SN38 and Snail-specific siRNA as a useful anticancer approach against prostate cancer.
Afkham A; Aghebati-Maleki L; Siahmansouri H; Sadreddini S; Ahmadi M; Dolati S; Afkham NM; Akbarzadeh P; Jadidi-Niaragh F; Younesi V; Yousefi M
Pharmacol Rep; 2018 Jun; 70(3):418-425. PubMed ID: 29626645
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus-delivered short hairpin-structured RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: a preclinical study.
Sun A; Tang J; Terranova PF; Zhang X; Thrasher JB; Li B
Int J Cancer; 2010 Feb; 126(3):764-74. PubMed ID: 19642108
[TBL] [Abstract][Full Text] [Related]
20. Akt1 and Jak1 siRNA based silencing effects on the proliferation and apoptosis in head and neck squamous cell carcinoma.
Vakili Saatloo M; Aghbali AA; Koohsoltani M; Yari Khosroushahi A
Gene; 2019 Sep; 714():143997. PubMed ID: 31348981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
